Medicare Enrolled
Dr. Jeffrey Cizenski, MD
Dermatology · East Syracuse, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cizenski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cizenski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cizenski
Dr. Jeffrey Cizenski is a dermatology specialist in East Syracuse, NY, with 13 years of NPI registration. Based on federal Medicare data, Dr. Cizenski performed 44,666 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Cizenski received a total of $753,565 from 40 pharmaceutical and/or device companies across 1459 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cizenski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years of NPI registration
▲ Top 0% volume in NY
$753,565 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗44,666
Medicare services
Top 0% in NY for dermatology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Photodynamic therapy gel for precancerous skin | 41,000 | $1 | $3 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
706 | $5 | $11 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
657 | $59 | $152 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
549 | $35 | $113 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
407 | $83 | $186 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
215 | $62 | $171 |
| Light application with debridement to destroy precancerous skin growth This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths. |
203 | $207 | $478 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
179 | $72 | $191 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
121 | $81 | $206 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
54 | $114 | $284 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth measuring 0.6 to 1.0 cm from the scalp, neck, hands, feet, or genitals. |
53 | $81 | $208 |
| Skin growth shaving, 0.5 cm or less This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs. |
52 | $55 | $173 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
52 | $63 | $186 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
47 | $37 | $85 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
47 | $94 | $416 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
45 | $293 | $675 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
38 | $302 | $724 |
| Shaving of skin growth on face, 0.6-1.0 cm This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters. |
35 | $86 | $233 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
28 | $89 | $210 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
24 | $116 | $278 |
| Punch biopsy of additional skin growth A small circular tool is used to remove a sample of an extra skin growth for laboratory examination. |
23 | $45 | $98 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
23 | $31 | $96 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
23 | $1 | $2 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
20 | $96 | $472 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $43 | $96 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
13 | $57 | $165 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
12 | $62 | $289 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
12 | $131 | $301 |
| Shaving of skin growth, 1.1-2.0 cm This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs. |
11 | $86 | $228 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$753,565
Total received (2018-2024)
Avg $107,652/year across 7 years
Top 2% in NY for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
1,459
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$199,020
2023
$247,917
2022
$192,918
2021
$73,753
2020
$38,672
2019
$565
2018
$720
Payments by company (2024)
Amgen Inc.
$37,749
Dermavant Sciences, Inc.
$26,771
Incyte Corporation
$26,619
ABBVIE INC.
$25,947
Janssen Biotech, Inc.
$22,966
SUN PHARMACEUTICAL INDUSTRIES INC.
$19,130
LEO Pharma Inc.
$16,952
GENZYME CORPORATION
$8,120
Lilly USA, LLC
$6,682
UCB, Inc.
$4,522
Regeneron Healthcare Solutions, Inc.
$2,658
E.R. Squibb & Sons, L.L.C.
$252
PFIZER INC.
$202
Biofrontera Inc.
$194
Arcutis Biotherapeutics, Inc.
$81
Novartis Pharmaceuticals Corporation
$74
Janssen Scientific Affairs, LLC
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Galderma Laboratories, L.P.
$17
Ascensia Diabetes Care Us Inc.
$14
Blueprint Medicines Corporation
$13
Top 3 companies account for 45.8% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$208,956
ABBVIE INC.
$86,138
Lilly USA, LLC
$81,325
Incyte Corporation
$81,254
Dermavant Sciences, Inc.
$65,696
LEO Pharma Inc.
$55,643
AbbVie Inc.
$49,369
Regeneron Healthcare Solutions, Inc.
$31,975
Janssen Biotech, Inc.
$25,159
GENZYME CORPORATION
$19,413
SUN PHARMACEUTICAL INDUSTRIES INC.
$19,191
Galderma Laboratories, L.P.
$15,372
UCB, Inc.
$4,740
PFIZER INC.
$3,019
NOVARTIS PHARMACEUTICALS CORPORATION
$3,000
Sun Pharmaceutical Industries Inc.
$675
Novartis Pharmaceuticals Corporation
$508
E.R. Squibb & Sons, L.L.C.
$414
AbbVie, Inc.
$335
Biofrontera Inc.
$318
VYNE Pharmaceuticals Inc.
$251
Arcutis Biotherapeutics, Inc.
$172
Boehringer Ingelheim Pharmaceuticals, Inc.
$105
SANOFI-AVENTIS U.S. LLC
$77
Misonix Inc
$57
PruGen, Inc. Pharmaceuticals
$57
Janssen Scientific Affairs, LLC
$55
Celgene Corporation
$49
Blueprint Medicines Corporation
$41
Fresenius Kabi USA, LLC
$33
DUSA Pharmaceuticals, Inc.
$22
Genentech USA, Inc.
$21
ORGANOGENESIS INC.
$20
Nabriva Therapeutics, plc
$18
DERMIRA, INC.
$17
Helsinn Therapeutics (U.S.), Inc.
$15
Mylan Pharmaceuticals Inc.
$14
Myriad Genetic Laboratories, Inc.
$14
Ascensia Diabetes Care Us Inc.
$14
Almirall LLC
$13
Top 3 companies account for 50.0% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMELUZ · AMZEEQ · AYVAKIT · Ameluz · BLU-U · Bimzelx · CIBINQO · COSENTYX · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · EVERSENSE E3 SENSOR KIT - RETAIL · Enbrel · FABRAZYME · FINACEA · HUMIRA · Humira · ILUMYA · Ilumya · LEVULAN KERASTICK · LIBTAYO · OPZELURA · ORACEA · Odomzo · Otezla · Puraply · QBREXZA · REMICADE · RINVOQ · Rituxan · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sivextro · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · VALCHLOR · VTAMA · Winlevi · XOLAIR · ZILXI · Zoryve · myPath
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
18
County median income
$74,740
Nearest hospital to ZIP centroid (approximate)
ST JOSEPH'S HOSPITAL HEALTH CENTER
5.7 mi
5.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cizenski is a mixed practice specialist, with above-average Medicare volume (top 0% in NY).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cizenski experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Cizenski performed 41,000 photodynamic therapy gel for precancerous skin services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Cizenski receive payments from pharmaceutical companies?
Yes. Dr. Cizenski received a total of $753,565 from 40 companies across 1,459 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cizenski's costs compare to other dermatologists in East Syracuse?
Dr. Cizenski's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cizenski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in East Syracuse
Browse dermatologists in East Syracuse ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in NY
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in NY
Which NY dermatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology